ACAT1 and atherosclerosis: In Apoe-/- mice liraglutide suppressed acyl-coenzyme A cholesterol acyltransferase 1 (Acat1) expression, foam cell formation and decreased atherosclerosis [38], and inhibited progression of early-onset atherosclerosis lesions in a GLP1R-dependent fashion [87].